
|Articles|April 2, 2020
COVID-19: Impact of pandemic on Switzerland's ophthalmic space
Author(s)Alex Delaney-Gesing
Advertisement
Roberto Pinelli, MD, CEO and founder of the
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Ophthalmic drug shortages more frequent, longer lasting than average
2
NovaBridge, Visara report positive phase 2a results for dual VEGF-A/ANG-2 inhibitor VIS-101
3
Genetic Retinoblastoma Risk Stratified by Age Among Patients with Metachronous Bilateral Conversion
4
Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
5


































